arXiv subjects

Alessia Melegaro

Publications and source records attributed to Alessia Melegaro.

5 recordsLinked to original sources

arXiv2026

A systematic review of COVID-19 epidemic models with endogenous human behaviour. What's next?

Human behaviour and epidemic dynamics are intertwined, yet accounting for this feedback remains one of the key challenges of epidemiological modelling. The COVID-19 pandemic was an opportunity to overcome the traditional limitations of the field, raising expectations that data-informed endogenous approaches to behaviour modelling would advance substantially. To quantify the progresses made, we conducted a systematic review of SARS-CoV-2 transmission models endogenously including human behaviour in response to epidemic dynamics. The COVID-19 pandemic saw great strides in terms of the expanded use of empirical data in epi-behavioural modelling. However, it also showed shortcomings with respect to limited use of behavioural empirical data, lack of innovation in model structure, and limited engagement with other disciplines and decision-makers. Overall, our results suggest that identifying priorities in model design and behavioural data, building an adequate data collection infrastructure, leveraging on AI advancements, and fostering interdisciplinarity are strategies of utmost importance for pandemic preparedness.

physics.soc-ph↗

arXiv2024

Post-pandemic social contacts in Italy: implications for social distancing measures on in-person school and work attendance

The collection of updated data on social contact patterns following the COVID-19 pandemic disruptions is crucial for future epidemiological assessments and evaluating non-pharmaceutical interventions (NPIs) based on physical distancing. We conducted two waves of an online survey in March 2022 and March 2023 in Italy, gathering data from a representative population sample on direct (verbal/physical interactions) and indirect (prolonged co-location in indoor spaces) contacts. Using a generalized linear mixed model, we examined determinants of individuals' total social contacts and evaluated the potential impact of work-from-home and distance learning on the transmissibility of respiratory pathogens. In-person attendance at work or school emerged as a primary driver of social contacts. Adults attending in person reported a mean of 1.69 (95% CI: 1.56-1.84) times the contacts of those staying home; among children and adolescents, this ratio increased to 2.38 (95% CI: 1.98-2.87). We estimated that suspending all non-essential work alone would marginally reduce transmissibility. However, combining distance learning for all education levels with work-from-home policies could decrease transmissibility by up to 23.7% (95% CI: 18.2%-29.0%). Extending these measures to early childcare services would yield only minimal additional benefits. These results provide useful data for modelling the transmission of respiratory pathogens in Italy after the end of the COVID-19 emergency. They also provide insights into the potential epidemiological effectiveness of social distancing interventions targeting work and school attendance, supporting considerations on the balance between the expected benefits and their heavy societal costs.

physics.soc-ph↗

arXiv2021

A quantitative assessment of epidemiological parameters to model COVID- 19 burden

Solid estimates describing the clinical course of SARS-CoV-2 infections are still lacking due to under-ascertainment of asymptomatic and mild-disease cases. In this work, we quantify age-specific probabilities of transitions between stages defining the natural history of SARS-CoV-2 infection from 1,965 SARS-CoV-2 positive individuals identified in Italy between March and April 2020 among contacts of confirmed cases. Infected contacts of cases were confirmed via RT-PCR tests as part of contact tracing activities or retrospectively via IgG serological tests and followed-up for symptoms and clinical outcomes. In addition, we provide estimates of time intervals between key events defining the clinical progression of cases as obtained from a larger sample, consisting of 95,371 infections ascertained between February and July 2020. We found that being older than 60 years of age was associated with a 39.9% (95%CI: 36.2-43.6%) likelihood of developing respiratory symptoms or fever >= 37.5 °C after SARS-CoV-2 infection; the 22.3% (95%CI: 19.3-25.6%) of the infections in this age group required hospital care and the 1% (95%CI: 0.4-2.1%) were admitted to an intensive care unit (ICU). The corresponding proportions in individuals younger than 60 years were estimated at 27.9% (95%CI: 25.4-30.4%), 8.8% (95%CI: 7.3-10.5%) and 0.4% (95%CI: 0.1-0.9%), respectively. The infection fatality ratio (IFR) ranged from 0.2% (95%CI: 0.0-0.6%) in individuals younger than 60 years to 12.3% (95%CI: 6.9-19.7%) for those aged 80 years or more; the case fatality ratio (CFR) in these two age classes was 0.6% (95%CI: 0.1-2%) and 19.2% (95% CI: 10.9-30.1%), respectively. The median length of stay in hospital was 10 (IQR 3-21) days; the length of stay in ICU was 11 (IQR 6-19) days. The obtained estimates could be instrumental to refine mathematical modeling work supporting public health decisions.

q-bio.PE↗

arXiv2020

Infection fatality ratio of SARS-CoV-2 in Italy

We analyzed 5,484 close contacts of COVID-19 cases from Italy, all of them tested for SARS-CoV-2 infection. We found an infection fatality ratio of 2.2% (95%CI 1.69-2.81%) and identified male sex, age >70 years, cardiovascular comorbidities, and infection early in the epidemics as risk factors for death.

q-bio.PE↗

arXiv2020

Probability of symptoms and critical disease after SARS-CoV-2 infection

We quantified the probability of developing symptoms (respiratory or fever \geq 37.5 °C) and critical disease (requiring intensive care or resulting in death) of SARS-CoV-2 positive subjects. 5,484 contacts of SARS-CoV-2 index cases detected in Lombardy, Italy were analyzed, and positive subjects were ascertained via nasal swabs and serological assays. 73.9% of all infected individuals aged less than 60 years did not develop symptoms (95% confidence interval: 71.8-75.9%). The risk of symptoms increased with age. 6.6% of infected subjects older than 60 years had critical disease, with males at significantly higher risk.

q-bio.PE↗